COVISHIELD Completes Enrolment of Phase III clinical trials under partnership of ICMR and SII
Serum Institute of India (SII), and Indian Council of Medical Research (ICMR), announce completion of enrolment of phase 3 clinical trials for COVISHIELD in India. ICMR and SII have further collaborated for clinical development of COVOVAX (Novavax) developed by Novavax, USA and upscaled by SII. ICMR has funded the clinical trial site fees while SII … Read more